Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pomper

Showing results (411-420 of 525) with videos related to

Pageof 53
Sort By:
Journal of Neuroinflammation|November 18, 2020
Correction to: Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infectionFarina J Mahmud, Yong Du, Elizabeth Greif, et al.
Cancer Research|August 27, 2009
Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancerShawn M Hillier, Kevin P Maresca, Frank J Femia, et al.
European Urology|July 6, 2023
Prostate-specific Membrane Antigen Reporting and Data System Version 2.0Rudolf A Werner, Philipp E Hartrampf, Wolfgang P Fendler, et al.
Theranostics|January 7, 2020
<sup>18</sup>F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular ImagingRudolf A Werner, Thorsten Derlin, Constantin Lapa, et al.
Molecular Imaging and Biology|May 30, 2019
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [<sup>18</sup>F]DCFPyL: Impact of Tumor Burden on Normal Organ UptakeRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine CarcinomasAlexander Weich, Rudolf A Werner, Andreas K Buck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 30, 2019
Preclinical Evaluation of <sup>203/212</sup>Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate CancerSangeeta Ray Banerjee, Il Minn, Vivek Kumar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2021
An Improved <sup>211</sup>At-Labeled Agent for PSMA-Targeted α-TherapyRonnie C Mease, Choong Mo Kang, Vivek Kumar, et al.
Journal of Cardiovascular Translational Research|January 10, 2014
Sex differences in translocator protein 18 kDa (TSPO) in the heart: implications for imaging myocardial inflammationDeLisa Fairweather, Michael J Coronado, Amanda E Garton, et al.
Scientific Reports|March 22, 2016
ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancerDong Gil You, V G Deepagan, Wooram Um, et al.
Pageof 53

Showing results (411-420 of 525) with videos related to

Sort By:
Pageof 53
Journal of Neuroinflammation|November 18, 2020
Correction to: Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infectionFarina J Mahmud, Yong Du, Elizabeth Greif, et al.
Cancer Research|August 27, 2009
Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancerShawn M Hillier, Kevin P Maresca, Frank J Femia, et al.
European Urology|July 6, 2023
Prostate-specific Membrane Antigen Reporting and Data System Version 2.0Rudolf A Werner, Philipp E Hartrampf, Wolfgang P Fendler, et al.
Theranostics|January 7, 2020
<sup>18</sup>F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular ImagingRudolf A Werner, Thorsten Derlin, Constantin Lapa, et al.
Molecular Imaging and Biology|May 30, 2019
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [<sup>18</sup>F]DCFPyL: Impact of Tumor Burden on Normal Organ UptakeRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine CarcinomasAlexander Weich, Rudolf A Werner, Andreas K Buck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 30, 2019
Preclinical Evaluation of <sup>203/212</sup>Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate CancerSangeeta Ray Banerjee, Il Minn, Vivek Kumar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2021
An Improved <sup>211</sup>At-Labeled Agent for PSMA-Targeted α-TherapyRonnie C Mease, Choong Mo Kang, Vivek Kumar, et al.
Journal of Cardiovascular Translational Research|January 10, 2014
Sex differences in translocator protein 18 kDa (TSPO) in the heart: implications for imaging myocardial inflammationDeLisa Fairweather, Michael J Coronado, Amanda E Garton, et al.
Scientific Reports|March 22, 2016
ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancerDong Gil You, V G Deepagan, Wooram Um, et al.
Pageof 53